|
Characteristics
|
CPC 3–5
|
CPC 1–2
|
Sensitivity, % (95% CI)
|
Specificity, % (95% CI)
|
FPR, % (95% CI)
|
PPV, % (95% CI)
|
NPV, % (95% CI)
|
|---|
|
BLS TOR rule
|
|
The Group of 2015
|
865
|
18
|
86.7 (84.2–88.9)
|
61.1 (36.1–81.7)
|
38.9 (18.3–63.9)
|
99.0 (98.0–99.6)
|
8.7 (4.7–15.4)
|
|
Met criteria
|
750
|
7
|
|
Not met criteria
|
115
|
11
|
|
The Group of 2020
|
558
|
14
|
78.1 (74.4–81.5)
|
85.7 (56.2–97.5)
|
14.3 (2.5–43.8)
|
99.5 (98.2–99.9)
|
9.0 (4.9–15.4)
|
|
Met criteria
|
436
|
2
|
|
Not met criteria
|
122
|
12
|
|
ALS TOR rule
|
|
The Group of 2015
|
361
|
16
|
34.0 (29.2–39.2)
|
93.8 (67.7–99.7)
|
6.2 (0.3–32.3)
|
99.2 (94.9–100.0)
|
5.9 (3.5–9.8)
|
|
Met criteria
|
123
|
1
|
|
Not met criteria
|
238
|
15
|
|
The Group of 2020
|
390
|
17
|
26.7 (22.4–31.4)
|
100.0 (77.1–100.0)
|
0 (0.0–22.9)
|
100.0 (95.6–100.0)
|
5.6 (3.4–9.0)
|
|
Met criteria
|
104
|
0
|
|
Not met criteria
|
286
|
17
|
- TOR Termination Of Resuscitation, CPC Cerebral Performance Category, CI Confidence Interval, FPR False-Positive Rate, PPV Positive Predictive Value, NPV Negative Predictive Value, BLS Basic Life Support, ALS Advanced Life Support
